Serial Number | 90244053 |
Word Mark | EMPOWER PHARMA |
Filing Date | Friday, October 9, 2020 |
Status | 602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE |
Status Date | Thursday, December 14, 2023 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
Published for Opposition Date | NOT AVAILABLE |
Description of Mark | The mark consists of right and left bracket overlapping design and to the right of the brackets the word, EMPOWER, with the word, PHARMA underneath. |
Goods and Services | Sterile prescription pharmaceuticals for human use, namely, sterile injectable pharmaceuticals, namely, compounded sterile injectable pharmaceuticals;, namely, medications, vitamins, minerals, and supplements, namely, alpha-lipoic acid, ascorbic acid, bacteriostatic water, branched-chain amino acids, vitamin B, mixtures of papaverine and phentolamine, calcium gluconate, mixtures of gamma-aminobutyric acid and magnesium chloride hexahydrate and taurine and theanine, ubiquinone, cyanocobalamin, dexpanthenol, edetate disodium, urofollitropin, growth hormone releasing peptides, human chorionic gonadotropin, ipamoreline acetate, l-arginine HCl, l-carnitine, mixtures of methionine and inositol and choline chloride and cyanocobalamin, mixtures of methionine and inositol and choline chloride and l-carnitine and thiamine HCl and dexpanthenol, mixtures of methionine and inositol and choline chloride, l-lysine HCl, menotropins, methylcobalamin, nandrolone decanoate, phenylephrine HCl, progesterone, pyridoxine HCl, mixtures of papaverine and phentolamine mesylate and prostaglandin and atropine sulfate, sermoreline acetate, sodium bicarbonate, taurine, testosterone cypionate, mixtures of testosterone cypionate and testosterone propionate, testosterone enanthate, testosterone propionate, mixtures of l-arginine HCL and l-citrulline and l-ornithine HCl, and mixtures of papaverine and phentolamine mesylate and prostaglandin E1 |
Disclaimer with Predetermined Text | "PHARMA" |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Tuesday, November 24, 2020 |
Primary Code | 005 |
First Use Anywhere Date | Wednesday, October 7, 2020 |
First Use In Commerce Date | Wednesday, October 7, 2020 |
Party Name | Empower Pharma, LLC |
Party Type | 10 - Original Applicant |
Legal Entity Type | 16 - Limited Liability Company |
Address | Houston, TX 77041 |
Event Date | Event Description |
Thursday, December 14, 2023 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |
Thursday, December 14, 2023 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |
Thursday, December 14, 2023 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
Wednesday, August 30, 2023 | NOTIFICATION OF FINAL REFUSAL EMAILED |
Wednesday, August 30, 2023 | FINAL REFUSAL E-MAILED |
Wednesday, August 30, 2023 | FINAL REFUSAL WRITTEN |
Thursday, March 2, 2023 | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED |
Monday, August 29, 2022 | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED |
Monday, February 28, 2022 | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED |
Friday, August 27, 2021 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
Friday, August 27, 2021 | LETTER OF SUSPENSION E-MAILED |
Friday, August 27, 2021 | SUSPENSION LETTER WRITTEN |
Thursday, August 26, 2021 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Wednesday, August 25, 2021 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Wednesday, August 25, 2021 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Wednesday, March 10, 2021 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Wednesday, March 10, 2021 | NON-FINAL ACTION E-MAILED |
Wednesday, March 10, 2021 | NON-FINAL ACTION WRITTEN |
Wednesday, March 10, 2021 | ASSIGNED TO EXAMINER |
Wednesday, November 25, 2020 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
Tuesday, November 24, 2020 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Tuesday, October 13, 2020 | NEW APPLICATION ENTERED |